#begin document (nw/wsj/03/wsj_0339); part 000
nw/wsj/03/wsj_0339   0    0        -LRB-   -LRB-        (TOP(S*        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0    1        During      IN          (PP*        -    -   -   -        *    (ARGM-TMP*   -
nw/wsj/03/wsj_0339   0    2           its    PRP$          (NP*        -    -   -   -   (DATE*             *   -
nw/wsj/03/wsj_0339   0    3    centennial      JJ             *        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0    4          year      NN            *))       -    -   -   -        *)            *)  -
nw/wsj/03/wsj_0339   0    5             ,       ,             *        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0    6           The      DT          (NP*        -    -   -   -    (ORG*        (ARG0*   -
nw/wsj/03/wsj_0339   0    7          Wall     NNP         (NML*        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0    8        Street     NNP             *)       -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0    9       Journal     NNP             *)       -    -   -   -        *)            *)  -
nw/wsj/03/wsj_0339   0   10          will      MD          (VP*        -    -   -   -        *    (ARGM-MOD*)  -
nw/wsj/03/wsj_0339   0   11        report      VB          (VP*    report  01   -   -        *           (V*)  -
nw/wsj/03/wsj_0339   0   12        events     NNS    (NP(NP(NP*)       -    -   -   -        *        (ARG1*   -
nw/wsj/03/wsj_0339   0   13            of      IN          (PP*        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   14           the      DT          (NP*        -    -   -   -   (DATE*             *   -
nw/wsj/03/wsj_0339   0   15          past      JJ             *        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   16       century      NN           *)))       -    -   -   -        *)            *   -
nw/wsj/03/wsj_0339   0   17          that     WDT   (SBAR(WHNP*)       -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   18         stand      NN        (S(VP*        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   19            as      IN          (PP*        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   20    milestones     NNS       (NP(NP*)       -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   21            of      IN          (PP*        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   22      American      JJ          (NP*        -    -   -   -    (NORP)            *   -
nw/wsj/03/wsj_0339   0   23      business      NN             *        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   24       history      NN    *))))))))))       -    -   -   -        *             *)  -
nw/wsj/03/wsj_0339   0   25             .       .             *        -    -   -   -        *             *   -
nw/wsj/03/wsj_0339   0   26        -RRB-   -RRB-             *))       -    -   -   -        *             *   -

nw/wsj/03/wsj_0339   0    0     LUTHER    NNP  (TOP(S(NP*         -    -   -   -   (PERSON*   (ARG0*   -
nw/wsj/03/wsj_0339   0    1    BURBANK    NNP           *)        -    -   -   -          *)       *)  -
nw/wsj/03/wsj_0339   0    2      CROSS     VB        (VP*         -    -   -   -          *        *   -
nw/wsj/03/wsj_0339   0    3         -    HYPH           *         -    -   -   -          *        *   -
nw/wsj/03/wsj_0339   0    4       BRED    VBD           *      breed   -   2   -          *        *   -
nw/wsj/03/wsj_0339   0    5     PLANTS    NNS        (NP*)        -    -   -   -          *        *   -
nw/wsj/03/wsj_0339   0    6         to     TO      (S(VP*         -    -   -   -          *        *   -
nw/wsj/03/wsj_0339   0    7    produce     VB        (VP*    produce  01   -   -          *      (V*)  -
nw/wsj/03/wsj_0339   0    8        the     DT        (NP*         -    -   -   -          *   (ARG1*   -
nw/wsj/03/wsj_0339   0    9    billion     CD       (NML*         -    -   -   -    (MONEY*        *   -
nw/wsj/03/wsj_0339   0   10         -    HYPH           *         -    -   -   -          *        *   -
nw/wsj/03/wsj_0339   0   11     dollar     NN           *)        -    -   -   -          *)       *   -
nw/wsj/03/wsj_0339   0   12      Idaho    NNP           *         -    -   -   -       (GPE)       *   -
nw/wsj/03/wsj_0339   0   13     potato     NN       *)))))        -    -   -   -          *        *)  -
nw/wsj/03/wsj_0339   0   14          .      .          *))        -    -   -   -          *        *   -

nw/wsj/03/wsj_0339   0    0      Bioengineers   NNS   (TOP(S(NP*)          -    -   -   -   *    (ARG0*)      (ARG0*)  -
nw/wsj/03/wsj_0339   0    1               set   VBD         (VP*          set  07   -   -   *       (V*)           *   -
nw/wsj/03/wsj_0339   0    2               out    RP        (PRT*)          -    -   -   -   *         *            *   -
nw/wsj/03/wsj_0339   0    3                to    TO       (S(VP*           -    -   -   -   *    (ARG1*            *   -
nw/wsj/03/wsj_0339   0    4         duplicate    VB         (VP*    duplicate  01   1   -   *         *          (V*)  -
nw/wsj/03/wsj_0339   0    5              that    DT         (NP*           -    -   -   -   *         *       (ARG1*   -
nw/wsj/03/wsj_0339   0    6              feat    NN            *)          -    -   -   -   *         *            *)  -
nw/wsj/03/wsj_0339   0    7               --      :            *           -    -   -   -   *         *            *   -
nw/wsj/03/wsj_0339   0    8    scientifically    RB       (ADVP*           -    -   -   -   *         *   (ARGM-MNR*   -
nw/wsj/03/wsj_0339   0    9               and    CC            *           -    -   -   -   *         *            *   -
nw/wsj/03/wsj_0339   0   10      commercially    RB            *)          -    -   -   -   *         *            *)  -
nw/wsj/03/wsj_0339   0   11               --      :            *           -    -   -   -   *         *            *   -
nw/wsj/03/wsj_0339   0   12              with    IN         (PP*           -    -   -   -   *         *   (ARGM-MNR*   -
nw/wsj/03/wsj_0339   0   13               new    JJ         (NP*           -    -   -   -   *         *            *   -
nw/wsj/03/wsj_0339   0   14              life    NN            *           -    -   -   -   *         *            *   -
nw/wsj/03/wsj_0339   0   15             forms   NNS       *))))))          -    -   -   -   *         *)           *)  -
nw/wsj/03/wsj_0339   0   16                 .     .           *))          -    -   -   -   *         *            *   -

nw/wsj/03/wsj_0339   0    0                  In      IN   (TOP(S(PP*        -    -   -   -          *   (ARGM-TMP*   -
nw/wsj/03/wsj_0339   0    1               1953       CD        (NP*))       -    -   -   -      (DATE)           *)  -
nw/wsj/03/wsj_0339   0    2                   ,       ,            *        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0    3               James     NNP      (NP(NP*        -    -   -   -   (PERSON*       (ARG0*   -
nw/wsj/03/wsj_0339   0    4              Watson     NNP            *)       -    -   -   -          *)           *   -
nw/wsj/03/wsj_0339   0    5                 and      CC            *        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0    6                 his    PRP$         (NP*        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0    7          colleagues     NNS           *))       -    -   -   -          *            *)  -
nw/wsj/03/wsj_0339   0    8            unlocked     VBD         (VP*    unlock  01   1   -          *          (V*)  -
nw/wsj/03/wsj_0339   0    9                 the      DT      (NP(NP*        -    -   -   -          *       (ARG1*   -
nw/wsj/03/wsj_0339   0   10              double      JJ            *        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   11               helix      NN            *)       -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   12                  of      IN         (PP*        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   13                 DNA      NN      (NP(NP*)       -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   14              -LRB-   -LRB-             *        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   15    deoxyribonucleic      JJ         (NP*        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   16                acid      NN            *)       -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   17              -RRB-   -RRB-             *        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   18                   ,       ,            *        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   19                 the      DT      (NP(NP*        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   20             genetic      JJ            *        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   21                 key      NN            *)       -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   22                  to      IN         (PP*        -    -   -   -          *            *   -
nw/wsj/03/wsj_0339   0   23            heredity      NN   (NP*)))))))       -    -   -   -          *            *)  -
nw/wsj/03/wsj_0339   0   24                   .       .           *))       -    -   -   -          *            *   -

nw/wsj/03/wsj_0339   0    0           Twenty    CD  (TOP(S(ADVP(NP*            -    -   -   -       (DATE*   (ARGM-TMP*        *             *   -
nw/wsj/03/wsj_0339   0    1            years   NNS                *)           -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0    2            later    RB                *)           -    -   -   -            *)           *)       *             *   -
nw/wsj/03/wsj_0339   0    3                ,     ,                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0    4              two    CD          (NP(NP*            -    -   -   -    (CARDINAL)      (ARG0*   (ARG0*             *   -
nw/wsj/03/wsj_0339   0    5       California   NNP                *            -    -   -   -         (GPE)           *        *             *   -
nw/wsj/03/wsj_0339   0    6        academics   NNS                *)           -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0    7                ,     ,                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0    8          Stanley   NNP          (NP(NP*            -    -   -   -     (PERSON*            *        *             *   -
nw/wsj/03/wsj_0339   0    9            Cohen   NNP                *)           -    -   -   -            *)           *        *             *   -
nw/wsj/03/wsj_0339   0   10              and    CC                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0   11          Herbert   NNP             (NP*            -    -   -   -     (PERSON*            *        *             *   -
nw/wsj/03/wsj_0339   0   12            Boyer   NNP               *))           -    -   -   -            *)           *        *             *   -
nw/wsj/03/wsj_0339   0   13                ,     ,                *)           -    -   -   -            *            *)       *)            *   -
nw/wsj/03/wsj_0339   0   14             made   VBD             (VP*          make  01   -   -            *          (V*)       *             *   -
nw/wsj/03/wsj_0339   0   15               ``    ``             (NP*            -    -   -   -            *       (ARG1*        *             *   -
nw/wsj/03/wsj_0339   0   16      recombinant    JJ                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0   17               ''    ''                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0   18              DNA    NN                *)           -    -   -   -            *            *)       *             *   -
nw/wsj/03/wsj_0339   0   19                ,     ,                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0   20    transplanting   VBG           (S(VP*    transplant  01   1   -            *   (ARGM-ADV*      (V*)            *   -
nw/wsj/03/wsj_0339   0   21                a    DT          (NP(NP*            -    -   -   -            *            *   (ARG1*             *   -
nw/wsj/03/wsj_0339   0   22             toad    NN                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0   23               's   POS                *)           -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0   24             gene    NN                *)           -    -   -   -            *            *        *)            *   -
nw/wsj/03/wsj_0339   0   25             into    IN             (PP*            -    -   -   -            *            *   (ARG2*             *   -
nw/wsj/03/wsj_0339   0   26         bacteria   NNS          (NP(NP*)           -    -   -   -            *            *        *        (ARG0*)  -
nw/wsj/03/wsj_0339   0   27                ,     ,                *            -    -   -   -            *            *        *             *   -
nw/wsj/03/wsj_0339   0   28            which   WDT      (SBAR(WHNP*)           -    -   -   -            *            *        *      (R-ARG0*)  -
nw/wsj/03/wsj_0339   0   29             then    RB         (S(ADVP*)           -    -   -   -            *            *        *    (ARGM-TMP*)  -
nw/wsj/03/wsj_0339   0   30       reproduced   VBD             (VP*     reproduce  01   2   -            *            *        *           (V*)  -
nw/wsj/03/wsj_0339   0   31             toad    NN             (NP*            -    -   -   -            *            *        *        (ARG1*   -
nw/wsj/03/wsj_0339   0   32            genes   NNS        *)))))))))           -    -   -   -            *            *)       *)            *)  -
nw/wsj/03/wsj_0339   0   33                .     .               *))           -    -   -   -            *            *        *             *   -

nw/wsj/03/wsj_0339   0    0            When    WRB   (TOP(S(SBAR(WHADVP*)     -    -   -   -          *    (ARGM-TMP*)  (ARGM-TMP*   -
nw/wsj/03/wsj_0339   0    1           Boyer    NNP                (S(NP*)     -    -   -   -    (PERSON)       (ARG0*)           *   -
nw/wsj/03/wsj_0339   0    2             met    VBD                  (VP*    meet  02   -   -          *           (V*)           *   -
nw/wsj/03/wsj_0339   0    3          Robert    NNP               (NP(NP*      -    -   -   -   (PERSON*        (ARG1*            *   -
nw/wsj/03/wsj_0339   0    4         Swanson    NNP                     *)     -    -   -   -          *)            *            *   -
nw/wsj/03/wsj_0339   0    5               ,      ,                     *      -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0    6              an     DT               (NP(NP*      -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0    7          M.I.T.    NNP                (ADJP*      -    -   -   -       (ORG)            *            *   -
nw/wsj/03/wsj_0339   0    8              -    HYPH                     *      -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0    9         trained    VBN                     *)     -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0   10         chemist     NN                     *)     -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0   11              -    HYPH                     *      -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0   12          turned    VBN                  (VP*      -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0   13              -    HYPH                     *      -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0   14    entrepreneur     NN            (S(NP*)))))     -    -   -   -          *             *)           *   -
nw/wsj/03/wsj_0339   0   15              in     IN                  (PP*      -    -   -   -          *    (ARGM-TMP*            *   -
nw/wsj/03/wsj_0339   0   16           1976      CD              (NP*)))))     -    -   -   -      (DATE)            *)           *)  -
nw/wsj/03/wsj_0339   0   17               ,      ,                     *      -    -   -   -          *             *            *   -
nw/wsj/03/wsj_0339   0   18            they    PRP                  (NP*)     -    -   -   -          *             *       (ARG0*)  -
nw/wsj/03/wsj_0339   0   19             saw    VBD                  (VP*     see  01   -   -          *             *          (V*)  -
nw/wsj/03/wsj_0339   0   20          dollar     NN                  (NP*      -    -   -   -          *             *       (ARG1*   -
nw/wsj/03/wsj_0339   0   21           signs    NNS                    *))     -    -   -   -          *             *            *)  -
nw/wsj/03/wsj_0339   0   22               .      .                    *))     -    -   -   -          *             *            *   -

nw/wsj/03/wsj_0339   0    0         With    IN  (TOP(S(PP*      -    -   -   -         *   (ARGM-MNR*   -
nw/wsj/03/wsj_0339   0    1            $     $  (NP(NP(NP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    2         500     CD           *)     -    -   -   -    (MONEY)           *   -
nw/wsj/03/wsj_0339   0    3       apiece    RB     (ADVP*))     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    4          and    CC           *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    5           an    DT     (NP(NP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    6    injection    NN           *)     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    7           of    IN        (PP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    8      outside    JJ        (NP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    9      capital    NN       *)))))     -    -   -   -         *            *)  -
nw/wsj/03/wsj_0339   0   10            ,     ,           *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   11         they   PRP        (NP*)     -    -   -   -         *       (ARG0*)  -
nw/wsj/03/wsj_0339   0   12       formed   VBD        (VP*    form  01   -   -         *          (V*)  -
nw/wsj/03/wsj_0339   0   13    Genentech   NNP        (NP*      -    -   -   -     (ORG*       (ARG1*   -
nw/wsj/03/wsj_0339   0   14          Inc   NNP          *))     -    -   -   -         *)           *)  -
nw/wsj/03/wsj_0339   0   15            .     .          *))     -    -   -   -         *            *   -

nw/wsj/03/wsj_0339   0   0    Commercial     JJ  (TOP(S(NP*      -    -   -   -   *   (ARG1*   -
nw/wsj/03/wsj_0339   0   1          gene     NN           *      -    -   -   -   *        *   -
nw/wsj/03/wsj_0339   0   2            -    HYPH           *      -    -   -   -   *        *   -
nw/wsj/03/wsj_0339   0   3      splicing     NN           *)     -    -   -   -   *        *)  -
nw/wsj/03/wsj_0339   0   4           was    VBD        (VP*      -    -   -   -   *        *   -
nw/wsj/03/wsj_0339   0   5          born    VBN       (VP*))   bear  02   -   -   *      (V*)  -
nw/wsj/03/wsj_0339   0   6             .      .          *))     -    -   -   -   *        *   -

nw/wsj/03/wsj_0339   0    0       Genentech    NNP  (TOP(S(NP(NP(NP*       -    -   -   -        (ORG)        *   (ARG0*   -
nw/wsj/03/wsj_0339   0    1              's    POS                 *)      -    -   -   -           *         *        *   -
nw/wsj/03/wsj_0339   0    2           first     JJ                 *       -    -   -   -    (ORDINAL)        *        *   -
nw/wsj/03/wsj_0339   0    3         product     NN                 *)      -    -   -   -           *         *        *   -
nw/wsj/03/wsj_0339   0    4               ,      ,                 *       -    -   -   -           *         *        *   -
nw/wsj/03/wsj_0339   0    5               a     DT           (NP(NP*       -    -   -   -           *    (ARG1*        *   -
nw/wsj/03/wsj_0339   0    6           brain     NN                 *       -    -   -   -           *         *        *   -
nw/wsj/03/wsj_0339   0    7         protein     NN                 *)      -    -   -   -           *         *)       *   -
nw/wsj/03/wsj_0339   0    8          called    VBD              (VP*     call  01   -   -           *       (V*)       *   -
nw/wsj/03/wsj_0339   0    9    somatostatin     NN         (S(NP*))))      -    -   -   -           *    (ARG2*)       *   -
nw/wsj/03/wsj_0339   0   10               ,      ,                 *)      -    -   -   -           *         *        *)  -
nw/wsj/03/wsj_0339   0   11          proved    VBD              (VP*    prove  01   -   -           *         *      (V*)  -
nw/wsj/03/wsj_0339   0   12             its   PRP$              (NP*       -    -   -   -           *         *   (ARG1*   -
nw/wsj/03/wsj_0339   0   13      technology     NN                *))      -    -   -   -           *         *        *)  -
nw/wsj/03/wsj_0339   0   14               .      .                *))      -    -   -   -           *         *        *   -

nw/wsj/03/wsj_0339   0    0          The    DT  (TOP(S(S(NP(NP*         -    -   -   -            *   (ARG1*   (ARG0*         *           *        *   -
nw/wsj/03/wsj_0339   0    1         next    JJ                *)        -    -   -   -            *        *)       *         *           *        *   -
nw/wsj/03/wsj_0339   0    2           to    TO      (SBAR(S(VP*         -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0    3           be    VB             (VP*         -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0    4       cloned   VBN         (VP*)))))     clone  01   -   -            *      (V*)       *         *           *        *   -
nw/wsj/03/wsj_0339   0    5            ,     ,                *         -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0    6        human    JJ             (NP*         -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0    7      insulin    NN                *)        -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0    8            ,     ,                *)        -    -   -   -            *        *        *)        *           *        *   -
nw/wsj/03/wsj_0339   0    9          had   VBD             (VP*       have  03   -   -            *        *      (V*)        *           *        *   -
nw/wsj/03/wsj_0339   0   10       market    NN             (NP*         -    -   -   -            *        *   (ARG1*         *           *        *   -
nw/wsj/03/wsj_0339   0   11    potential    NN              *)))        -    -   -   -            *        *        *)        *           *        *   -
nw/wsj/03/wsj_0339   0   12          and    CC                *         -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0   13    Genentech   NNP           (S(NP*)        -    -   -   -         (ORG)       *        *    (ARG0*)          *        *   -
nw/wsj/03/wsj_0339   0   14     licensed   VBD             (VP*    license  01   1   -            *        *        *       (V*)          *        *   -
nw/wsj/03/wsj_0339   0   15           it   PRP             (NP*)        -    -   -   -            *        *        *    (ARG1*)          *        *   -
nw/wsj/03/wsj_0339   0   16           to    IN             (PP*         -    -   -   -            *        *        *    (ARG2*           *        *   -
nw/wsj/03/wsj_0339   0   17          Eli   NNP          (NP(NP*         -    -   -   -        (ORG*        *        *         *      (ARG0*        *   -
nw/wsj/03/wsj_0339   0   18        Lilly   NNP                *)        -    -   -   -            *)       *        *         *           *)       *   -
nw/wsj/03/wsj_0339   0   19            ,     ,                *         -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0   20        which   WDT      (SBAR(WHNP*)        -    -   -   -            *        *        *         *    (R-ARG0*)       *   -
nw/wsj/03/wsj_0339   0   21     produced   VBD           (S(VP*    produce  01   -   -            *        *        *         *         (V*)       *   -
nw/wsj/03/wsj_0339   0   22          80     CD          (NP(NP*         -    -   -   -    (PERCENT*        *        *         *      (ARG1*        *   -
nw/wsj/03/wsj_0339   0   23            %    NN                *)        -    -   -   -            *)       *        *         *           *        *   -
nw/wsj/03/wsj_0339   0   24           of    IN             (PP*         -    -   -   -            *        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0   25          the    DT          (NP(NP*         -    -   -   -            *        *        *         *           *   (ARG1*   -
nw/wsj/03/wsj_0339   0   26      insulin    NN                *)        -    -   -   -            *        *        *         *           *        *)  -
nw/wsj/03/wsj_0339   0   27         used   VBN             (VP*        use  01   -   -            *        *        *         *           *      (V*)  -
nw/wsj/03/wsj_0339   0   28           by    IN             (PP*         -    -   -   -            *        *        *         *           *   (ARG0*   -
nw/wsj/03/wsj_0339   0   29         1.5     CD          (NP(QP*         -    -   -   -   (CARDINAL*        *        *         *           *        *   -
nw/wsj/03/wsj_0339   0   30      million    CD                *)        -    -   -   -            *)       *        *         *           *        *   -
nw/wsj/03/wsj_0339   0   31         U.S.   NNP                *         -    -   -   -         (GPE)       *        *         *           *        *   -
nw/wsj/03/wsj_0339   0   32    diabetics   NNS    *)))))))))))))        -    -   -   -            *        *        *         *)          *)       *)  -
nw/wsj/03/wsj_0339   0   33            .     .               *))        -    -   -   -            *        *        *         *           *        *   -

nw/wsj/03/wsj_0339   0    0          Their   PRP$  (TOP(S(S(NP*           -    -   -   -          *   (ARG1*   (ARGM-ADV*   -
nw/wsj/03/wsj_0339   0    1     laboratory     NN             *           -    -   -   -          *        *            *   -
nw/wsj/03/wsj_0339   0    2    credentials    NNS             *)          -    -   -   -          *        *)           *   -
nw/wsj/03/wsj_0339   0    3    established    VBN         (VP*))   establish  01   -   -          *      (V*)           *)  -
nw/wsj/03/wsj_0339   0    4              ,      ,             *           -    -   -   -          *        *            *   -
nw/wsj/03/wsj_0339   0    5          Boyer    NNP          (NP*           -    -   -   -    (PERSON)       *       (ARG0*   -
nw/wsj/03/wsj_0339   0    6            and     CC             *           -    -   -   -          *        *            *   -
nw/wsj/03/wsj_0339   0    7        Swanson    NNP             *)          -    -   -   -    (PERSON)       *            *)  -
nw/wsj/03/wsj_0339   0    8         headed    VBD          (VP*         head  02   -   -          *        *          (V*)  -
nw/wsj/03/wsj_0339   0    9            for     IN          (PP*           -    -   -   -          *        *       (ARG1*   -
nw/wsj/03/wsj_0339   0   10           Wall    NNP          (NP*           -    -   -   -          *        *            *   -
nw/wsj/03/wsj_0339   0   11         Street    NNP            *))          -    -   -   -          *        *            *)  -
nw/wsj/03/wsj_0339   0   12             in     IN          (PP*           -    -   -   -          *        *   (ARGM-TMP*   -
nw/wsj/03/wsj_0339   0   13          1980      CD        (NP*)))          -    -   -   -      (DATE)       *            *)  -
nw/wsj/03/wsj_0339   0   14              .      .            *))          -    -   -   -          *        *            *   -

nw/wsj/03/wsj_0339   0    0            At      IN        (TOP(S(PP*      -    -   -   -         *   (ARGM-TMP*   -
nw/wsj/03/wsj_0339   0    1           the      DT              (NP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    2          time      NN                *))     -    -   -   -         *            *)  -
nw/wsj/03/wsj_0339   0    3             ,       ,                 *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    4     Genentech      NN              (NP*)     -    -   -   -      (ORG)      (ARG0*)  -
nw/wsj/03/wsj_0339   0    5           had     VBD              (VP*    have  03   -   -         *          (V*)  -
nw/wsj/03/wsj_0339   0    6          only      RB  (NP(NP(NP(NP(QP*      -    -   -   -    (DATE*       (ARG1*   -
nw/wsj/03/wsj_0339   0    7           one      CD                 *)     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    8    profitable      JJ                 *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    9          year      NN                 *)     -    -   -   -         *)           *   -
nw/wsj/03/wsj_0339   0   10        behind      IN              (PP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   11            it     PRP            (NP*)))     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   12        -LRB-   -LRB-                  *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   13             a      DT           (NP(NP*      -    -   -   -   (MONEY*            *   -
nw/wsj/03/wsj_0339   0   14        modest      JJ                 *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   15             $       $                 *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   16      116,000       CD                 *)     -    -   -   -         *)           *   -
nw/wsj/03/wsj_0339   0   17            on      IN              (PP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   18       revenue      NN           (NP(NP*)     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   19            of      IN              (PP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   20             $       $           (NP(QP*      -    -   -   -   (MONEY*            *   -
nw/wsj/03/wsj_0339   0   21          2.6       CD                 *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   22       million      CD               *)))     -    -   -   -         *)           *   -
nw/wsj/03/wsj_0339   0   23            in      IN              (PP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   24         1979       CD          (NP*)))))     -    -   -   -     (DATE)           *   -
nw/wsj/03/wsj_0339   0   25        -RRB-   -RRB-                  *)     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   26           and      CC                 *      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   27            no      DT           (NP(NP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   28       product      NN                 *)     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   29            of      IN              (PP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   30           its    PRP$              (NP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   31           own      JJ                *))     -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   32            on      IN              (PP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   33           the      DT              (NP*      -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   34        market      NN             *)))))     -    -   -   -         *            *)  -
nw/wsj/03/wsj_0339   0   35             .       .                *))     -    -   -   -         *            *   -

nw/wsj/03/wsj_0339   0    0    Nonetheless    RB   (TOP(S(ADVP*)      -    -   -   -         *            *    (ARGM-DIS*)   (ARGM-DIS*)  -
nw/wsj/03/wsj_0339   0    1              ,     ,              *       -    -   -   -         *            *             *             *   -
nw/wsj/03/wsj_0339   0    2            the    DT        (NP(NP*       -    -   -   -         *       (ARG1*        (ARG1*        (ARG1*   -
nw/wsj/03/wsj_0339   0    3              $     $       (NML(QP*       -    -   -   -   (MONEY*            *             *             *   -
nw/wsj/03/wsj_0339   0    4            36     CD              *       -    -   -   -         *            *             *             *   -
nw/wsj/03/wsj_0339   0    5        million    CD             *))      -    -   -   -         *)           *             *             *   -
nw/wsj/03/wsj_0339   0    6          issue    NN              *)      -    -   -   -         *            *)            *             *   -
nw/wsj/03/wsj_0339   0    7           they   PRP    (SBAR(S(NP*)      -    -   -   -         *       (ARG0*)            *             *   -
nw/wsj/03/wsj_0339   0    8        floated   VBD           (VP*    float  01   4   -         *          (V*)            *             *   -
nw/wsj/03/wsj_0339   0    9             in    IN           (PP*       -    -   -   -         *   (ARGM-TMP*             *             *   -
nw/wsj/03/wsj_0339   0   10          1980     CD      (NP*))))))      -    -   -   -     (DATE)           *)            *)            *)  -
nw/wsj/03/wsj_0339   0   11         opened   VBD        (VP(VP*     open  02   -   -         *            *           (V*)            *   -
nw/wsj/03/wsj_0339   0   12             at    IN           (PP*       -    -   -   -         *            *    (ARGM-EXT*             *   -
nw/wsj/03/wsj_0339   0   13              $     $           (NP*       -    -   -   -         *            *             *             *   -
nw/wsj/03/wsj_0339   0   14            35     CD            *)))      -    -   -   -    (MONEY)           *             *)            *   -
nw/wsj/03/wsj_0339   0   15            and    CC              *       -    -   -   -         *            *             *             *   -
nw/wsj/03/wsj_0339   0   16         leaped   VBD           (VP*     leap  01   1   -         *            *             *           (V*)  -
nw/wsj/03/wsj_0339   0   17             to    IN           (PP*       -    -   -   -         *            *             *        (ARG4*   -
nw/wsj/03/wsj_0339   0   18              $     $           (NP*       -    -   -   -         *            *             *             *   -
nw/wsj/03/wsj_0339   0   19            89     CD             *))      -    -   -   -    (MONEY)           *             *             *)  -
nw/wsj/03/wsj_0339   0   20         within    IN           (PP*       -    -   -   -         *            *             *    (ARGM-TMP*   -
nw/wsj/03/wsj_0339   0   21            20     CD           (NP*       -    -   -   -    (TIME*            *             *             *   -
nw/wsj/03/wsj_0339   0   22        minutes   NNS           *))))      -    -   -   -         *)           *             *             *)  -
nw/wsj/03/wsj_0339   0   23              .     .             *))      -    -   -   -         *            *             *             *   -

nw/wsj/03/wsj_0339   0    0        The    DT  (TOP(S(NP(NP*      -    -   -   -   *        *        (ARG1*   -
nw/wsj/03/wsj_0339   0    1       trip    NN              *)   trip  01   1   -   *      (V*)            *   -
nw/wsj/03/wsj_0339   0    2       from    IN           (PP*      -    -   -   -   *   (ARG2*             *   -
nw/wsj/03/wsj_0339   0    3        the    DT           (NP*      -    -   -   -   *        *             *   -
nw/wsj/03/wsj_0339   0    4       test    NN              *      -    -   -   -   *        *             *   -
nw/wsj/03/wsj_0339   0    5       tube    NN            *)))     -    -   -   -   *        *)            *)  -
nw/wsj/03/wsj_0339   0    6        was   VBD           (VP*      be  01   -   -   *        *           (V*)  -
nw/wsj/03/wsj_0339   0    7        not    RB              *      -    -   -   -   *        *    (ARGM-NEG*)  -
nw/wsj/03/wsj_0339   0    8    without    IN           (PP*      -    -   -   -   *        *        (ARG2*   -
nw/wsj/03/wsj_0339   0    9      snags   NNS         (NP*)))     -    -   -   -   *        *             *)  -
nw/wsj/03/wsj_0339   0   10          .     .             *))     -    -   -   -   *        *             *   -

nw/wsj/03/wsj_0339   0    0          Boyer    NNP  (TOP(S(S(NP(NP*        -    -   -   -    (PERSON)     *   (ARG1*   (ARG0*        *        *         *   -
nw/wsj/03/wsj_0339   0    1            and     CC                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    2          Cohen    NNP                *)       -    -   -   -    (PERSON)     *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    3              ,      ,                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    4            for     IN             (PP*        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    5       instance     NN            (NP*))       -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    6              ,      ,                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    7           both     DT             (NP*        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    8          still     RB                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0    9     university     NN                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   10    researchers    NNS                *)       -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   11              ,      ,                *)       -    -   -   -          *      *        *)       *)       *        *         *   -
nw/wsj/03/wsj_0339   0   12            had    VBD             (VP*      have  02   -   -          *    (V*)       *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   13             to     TO           (S(VP*        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   14             be     VB             (VP*        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   15         talked    VBN             (VP*      talk  02   -   -          *      *      (V*)       *        *        *         *   -
nw/wsj/03/wsj_0339   0   16           into     IN             (PP*        -    -   -   -          *      *   (ARG2*        *        *        *         *   -
nw/wsj/03/wsj_0339   0   17       applying    VBG           (S(VP*     apply  01   -   -          *      *        *      (V*)       *        *         *   -
nw/wsj/03/wsj_0339   0   18            for     IN             (PP*        -    -   -   -          *      *        *   (ARG1*        *        *         *   -
nw/wsj/03/wsj_0339   0   19              a     DT          (NP(NP*        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   20         patent     NN                *)   patent  01   1   -          *      *        *        *      (V*)       *         *   -
nw/wsj/03/wsj_0339   0   21             on     IN             (PP*        -    -   -   -          *      *        *        *   (ARG1*        *         *   -
nw/wsj/03/wsj_0339   0   22          their   PRP$             (NP*        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   23           gene     NN            (NML*        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   24             -    HYPH                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   25       splicing     NN                *)       -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   26      technique     NN    *)))))))))))))       -    -   -   -          *      *        *)       *)       *)       *         *   -
nw/wsj/03/wsj_0339   0   27            --       :                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   28            and     CC                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   29           then     RB           (ADVP*)       -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   30            the     DT           (S(NP*        -    -   -   -      (ORG*      *        *        *        *   (ARG0*    (ARG0*   -
nw/wsj/03/wsj_0339   0   31         Patent    NNP                *        -    -   -   -          *      *        *        *        *        *         *   -
nw/wsj/03/wsj_0339   0   32         Office    NNP                *)       -    -   -   -          *)     *        *        *        *        *)        *)  -
nw/wsj/03/wsj_0339   0   33        refused    VBD             (VP*    refuse  01   -   -          *      *        *        *        *      (V*)        *   -
nw/wsj/03/wsj_0339   0   34             to     TO           (S(VP*        -    -   -   -          *      *        *        *        *   (ARG1*         *   -
nw/wsj/03/wsj_0339   0   35          grant     VB             (VP*     grant  01   -   -          *      *        *        *        *        *       (V*)  -
nw/wsj/03/wsj_0339   0   36             it    PRP        (NP*))))))       -    -   -   -          *      *        *        *        *        *)   (ARG1*)  -
nw/wsj/03/wsj_0339   0   37              .      .               *))       -    -   -   -          *      *        *        *        *        *         *   -

nw/wsj/03/wsj_0339   0    0           That      DT  (TOP(S(NP*         -    -   -   -           *       (ARG1*        *        *        *             *   -
nw/wsj/03/wsj_0339   0    1       judgment      NN           *)        -    -   -   -           *            *)       *        *        *             *   -
nw/wsj/03/wsj_0339   0    2              ,       ,           *         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0    3             in      IN        (PP*         -    -   -   -           *   (ARGM-ADV*        *        *        *             *   -
nw/wsj/03/wsj_0339   0    4           turn      NN       (NP*))        -    -   -   -           *            *)       *        *        *             *   -
nw/wsj/03/wsj_0339   0    5              ,       ,           *         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0    6            was     VBD        (VP*         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0    7       reversed     VBN        (VP*    reverse  01   2   -           *          (V*)       *        *        *             *   -
nw/wsj/03/wsj_0339   0    8             by      IN        (PP*         -    -   -   -           *       (ARG0*        *        *        *             *   -
nw/wsj/03/wsj_0339   0    9            the      DT        (NP*         -    -   -   -       (ORG*            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   10           U.S.     NNP           *         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   11        Supreme     NNP           *         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   12          Court     NNP          *))        -    -   -   -           *)           *)       *        *        *             *   -
nw/wsj/03/wsj_0339   0   13              ,       ,           *         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   14        leaving     VBG      (S(VP*      leave  01   -   -           *   (ARGM-ADV*      (V*)       *        *             *   -
nw/wsj/03/wsj_0339   0   15          Cohen     NNP        (NP*         -    -   -   -     (PERSON)           *   (ARG1*   (ARG0*   (ARG0*             *   -
nw/wsj/03/wsj_0339   0   16            and      CC           *         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   17          Boyer     NNP           *)        -    -   -   -     (PERSON)           *        *)       *)       *)            *   -
nw/wsj/03/wsj_0339   0   18        holding     VBG      (S(VP*       hold  01   -   -           *            *   (ARG2*      (V*)       *             *   -
nw/wsj/03/wsj_0339   0   19            the      DT  (NP(NP(NP*         -    -   -   -           *            *        *   (ARG1*        *        (ARG1*   -
nw/wsj/03/wsj_0339   0   20          first      JJ           *         -    -   -   -    (ORDINAL)           *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   21        patents     NNS           *)        -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   22            for      IN        (PP*         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   23         making     VBG      (S(VP*       make  01   -   -           *            *        *        *      (V*)            *   -
nw/wsj/03/wsj_0339   0   24    recombinant      JJ        (NP*         -    -   -   -           *            *        *        *   (ARG1*             *   -
nw/wsj/03/wsj_0339   0   25            DNA     NNP       *)))))        -    -   -   -           *            *        *        *        *)            *)  -
nw/wsj/03/wsj_0339   0   26         -LRB-   -LRB-            *         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   27            now      RB   (VP(ADVP*)        -    -   -   -           *            *        *        *        *    (ARGM-TMP*)  -
nw/wsj/03/wsj_0339   0   28       assigned     VBN           *     assign  01   -   -           *            *        *        *        *           (V*)  -
nw/wsj/03/wsj_0339   0   29             to      IN        (PP*         -    -   -   -           *            *        *        *        *        (ARG2*   -
nw/wsj/03/wsj_0339   0   30          their    PRP$        (NP*         -    -   -   -           *            *        *        *        *             *   -
nw/wsj/03/wsj_0339   0   31        schools     NNS         *)))        -    -   -   -           *            *        *        *        *             *)  -
nw/wsj/03/wsj_0339   0   32         -RRB-   -RRB-      *)))))))        -    -   -   -           *            *)       *)       *)       *             *   -
nw/wsj/03/wsj_0339   0   33              .       .          *))        -    -   -   -           *            *        *        *        *             *   -

nw/wsj/03/wsj_0339   0    0        Gene     NN  (TOP(S(NP*    -    -   -   -   *        (ARG1*   -
nw/wsj/03/wsj_0339   0    1          -    HYPH           *    -    -   -   -   *             *   -
nw/wsj/03/wsj_0339   0    2    splicing     NN           *)   -    -   -   -   *             *)  -
nw/wsj/03/wsj_0339   0    3         now     RB      (ADVP*)   -    -   -   -   *    (ARGM-TMP*)  -
nw/wsj/03/wsj_0339   0    4          is    VBZ        (VP*    be  01   -   -   *           (V*)  -
nw/wsj/03/wsj_0339   0    5          an     DT     (NP(NP*    -    -   -   -   *        (ARG2*   -
nw/wsj/03/wsj_0339   0    6    integral     JJ           *    -    -   -   -   *             *   -
nw/wsj/03/wsj_0339   0    7        part     NN           *)   -    -   -   -   *             *   -
nw/wsj/03/wsj_0339   0    8          of     IN        (PP*    -    -   -   -   *             *   -
nw/wsj/03/wsj_0339   0    9         the     DT        (NP*    -    -   -   -   *             *   -
nw/wsj/03/wsj_0339   0   10        drug     NN           *    -    -   -   -   *             *   -
nw/wsj/03/wsj_0339   0   11    business     NN        *))))   -    -   -   -   *             *)  -
nw/wsj/03/wsj_0339   0   12           .      .          *))   -    -   -   -   *             *   -

nw/wsj/03/wsj_0339   0    0    Genentech     NN  (TOP(S(NP(NP*    -    -   -   -      (ORG)      (ARG1*   -
nw/wsj/03/wsj_0339   0    1           's    POS              *)   -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    2        1988      CD              *    -    -   -   -     (DATE)           *   -
nw/wsj/03/wsj_0339   0    3        sales    NNS              *)   -    -   -   -         *            *)  -
nw/wsj/03/wsj_0339   0    4         were    VBD           (VP*    be  01   -   -         *          (V*)  -
nw/wsj/03/wsj_0339   0    5            $      $        (NP(QP*    -    -   -   -   (MONEY*       (ARG2*   -
nw/wsj/03/wsj_0339   0    6         335      CD              *    -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    7      million     CD             *))   -    -   -   -         *)           *)  -
nw/wsj/03/wsj_0339   0    8            ,      ,              *    -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0    9         both     CC           (PP*    -    -   -   -         *   (ARGM-CAU*   -
nw/wsj/03/wsj_0339   0   10         from     IN              *    -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   11    licensing     NN           (NP*)   -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   12          and     CC              *    -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   13          its   PRP$           (NP*    -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   14          own     JJ              *    -    -   -   -         *            *   -
nw/wsj/03/wsj_0339   0   15     products    NNS            *)))   -    -   -   -         *            *)  -
nw/wsj/03/wsj_0339   0   16            .      .             *))   -    -   -   -         *            *   -

#end document
